ANTM
Income statement / Annual
Last year (2024), Elevance Health Inc.'s total revenue was $176.81 B,
an increase of 3.19% from the previous year.
In 2024, Elevance Health Inc.'s net income was $5.98 B.
See Elevance Health Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$176.81 B |
$171.34 B |
$156.60 B |
$138.64 B |
$121.87 B |
$104.21 B |
$92.11 B |
$90.04 B |
$84.98 B |
$79.24 B |
| Cost of Revenue |
$19.75 B
|
$124.33 B
|
$116.64 B
|
$102.65 B
|
$88.05 B
|
$81.79 B
|
$71.90 B
|
$72.24 B
|
$66.83 B
|
$61.12 B
|
| Gross Profit |
$157.06 B
|
$47.01 B
|
$39.95 B
|
$35.99 B
|
$33.82 B
|
$22.43 B
|
$20.21 B
|
$17.80 B
|
$18.14 B
|
$18.12 B
|
| Gross Profit Ratio |
0.89
|
0.27
|
0
|
0.26
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
-$148.88 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Other Expenses |
$168.91 B
|
$38.27 B
|
$31.50 B
|
$27.05 B
|
$26.11 B
|
$15.69 B
|
$14.37 B
|
$12.82 B
|
$12.72 B
|
$12.76 B
|
| Operating Expenses |
$20.03 B
|
$38.27 B
|
$31.50 B
|
$27.05 B
|
$26.11 B
|
$15.69 B
|
$14.37 B
|
$12.82 B
|
$12.72 B
|
$12.76 B
|
| Cost And Expenses |
$39.47 B
|
$162.60 B
|
$148.14 B
|
$129.69 B
|
$114.16 B
|
$97.48 B
|
$86.27 B
|
$85.05 B
|
$79.56 B
|
$73.88 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$1.19 B
|
$1.03 B
|
$851.00 M
|
$798.00 M
|
$784.00 M
|
$746.00 M
|
$753.00 M
|
$739.00 M
|
$723.00 M
|
$653.00 M
|
| Depreciation & Amortization |
$1.39 B
|
$1.75 B
|
$1.68 B
|
$1.30 B
|
$1.15 B
|
$485.00 M
|
$482.00 M
|
$279.10 M
|
$296.30 M
|
$335.90 M
|
| EBITDA |
$9.09 B |
$10.49 B |
$10.13 B |
$6.00 B |
$8.18 B |
$7.22 B |
$6.30 B |
$4.98 B |
$5.57 B |
$5.62 B |
| EBITDA Ratio |
0.05
|
0.06
|
0.06
|
0.07
|
0.06
|
0.07
|
0.07
|
0.05
|
0.06
|
0.07
|
| Operating Income Ratio |
0.78
|
0.78
|
0.05
|
0.06
|
0.06
|
0.06
|
0.06
|
0.06
|
0.06
|
0.07
|
| Total Other Income/Expenses Net |
-$129.33 B
|
-$1.03 B
|
-$851.00 M
|
-$1.02 B
|
-$1.47 B
|
-$748.00 M
|
-$769.00 M
|
-$1.02 B
|
-$863.70 M
|
-$727.10 M
|
| Income Before Tax |
$7.90 B
|
$7.72 B
|
$7.60 B
|
$7.93 B
|
$6.24 B
|
$5.99 B
|
$5.07 B
|
$3.96 B
|
$4.56 B
|
$4.63 B
|
| Income Before Tax Ratio |
0.04
|
0.05
|
0.05
|
0.06
|
0.05
|
0.06
|
0.06
|
0.04
|
0.05
|
0.06
|
| Income Tax Expense |
$1.93 B
|
$1.72 B
|
$1.71 B
|
$1.83 B
|
$1.67 B
|
$1.18 B
|
$1.32 B
|
$121.00 M
|
$2.09 B
|
$2.07 B
|
| Net Income |
$5.98 B
|
$5.99 B
|
$5.89 B
|
$6.10 B
|
$4.57 B
|
$4.81 B
|
$3.75 B
|
$3.84 B
|
$2.47 B
|
$2.56 B
|
| Net Income Ratio |
0.03
|
0.03
|
0.04
|
0.04
|
0.04
|
0.05
|
0.04
|
0.04
|
0.03
|
0.03
|
| EPS |
26.29 |
25.69 |
24.5583 |
25.0369 |
18.2297 |
18.8141 |
14.5292 |
14.6952 |
9.3945 |
9.7338 |
| EPS Diluted |
25.68 |
25.22 |
24.2751 |
24.7326 |
17.9788 |
18.4672 |
14.1938 |
14.3495 |
9.2122 |
9.3807 |
| Weighted Average Shares Out |
$227.48 M
|
$233.07 M
|
$240.00 M
|
$243.80 M
|
$250.80 M
|
$255.50 M
|
$254.30 M
|
$256.08 M
|
$263.75 M
|
$261.24 M
|
| Weighted Average Shares Out Diluted |
$232.90 M
|
$237.40 M
|
$242.80 M
|
$246.80 M
|
$254.30 M
|
$260.30 M
|
$254.30 M
|
$267.80 M
|
$268.10 M
|
$272.90 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
